NEW SCIENTIFIC STUDY FINDS EVIDENCE OF HYPERBARIC OXYGEN THERAPY EFFICACY FOR PATIENTS WITH MILD TRAUMATIC BRAIN INJURY
NEW SCIENTIFIC STUDY FINDS EVIDENCE OF HYPERBARIC OXYGEN THERAPY EFFICACY FOR PATIENTS WITH MILD TRAUMATIC BRAIN INJURY
Latest Scienceweekly.us article...
NEW SCIENTIFIC STUDY FINDS EVIDENCE OF HYPERBARIC OXYGEN THERAPY EFFICACY FOR PATIENTS WITH MILD TRAUMATIC BRAIN INJURY
March 26, 2022
HBOT at 1.5 ATA oxygen Promotes Symptomatic and Cognitive Improvements for Patients with mild Traumatic Brain Injury/Persistent Postconcussion Syndrome in a Narrow Range of Pressure
New Orleans, LA — March 26, 2022: Today, IPAK announced the publication of a systematic review (latest study) on hyperbaric oxygen therapy (HBOT) efficacy in mild traumatic brain injury Persistent Postconcussion Syndrome (PPCS).
Following multiple randomized and randomized controlled studies, the review found HBOT at 1.5 ATA oxygen to provide improvements in symptoms and cognition for patients with mild traumatic brain injury...
Read more...
https://scienceweekly.us/2022/03/28/lsuhyperbaricstudyharch/
Image Credit: LSU Health.
Wonderful! I remember Dr McCullough talking with another doctor about hyperbaric treatment for long covid.
The benefits of HBOT are under-appreciated in medicine. Thanks for covering it!